Sun Pharmaceutical Industries Ltd. announced that USFDA has granted tentative approval for the company’s Abbreviated New Drug Application (ANDA) for generic Razadyne tm, galantamine tablets. Galantamine is indicated for the treatment of mild to moderate dementia of the Alzheimer’s type. These generic versions of galantamine are bio-equivalent to Razadyne tm distributed by Ortho-McNeil Neurologics, Inc. The ANDA includes three strengths: tablets containing galantamine hydrobromide equivalent to 4mg, 8 mg and 12 mg base. These strengths of branded galantamine have annual sales of approximately USD 120 million in the US. Razadyne tm is a trademark of Johnson & Johnson. Sourced from: Sun Pharmaceutical Industries Ltd |
|
|
|
| View Comments | Post Comments |
| Headlines from Web18 |
Connect.in.com :- Indian Businesspeople | Indian CEOs | American Businesspeople | Insurance Companies | American Chief Executives | Australian Businesspeople | Mutual Funds | Brands | Businesspeople In Software | Online trading sites | Businesspeople In Steel | California Businesspeople | American Billionaires | CNBC-TV18 Anchors | Companies listed on the New York Stock Exchange | Businesspeople Of Indian Descent | Companies that have filed for Chapter 11 bankruptcy | Google Employees | Companies listed in India | Indian Economists | Indian Journalists | Indian Billionaires | Indian Mass Media Owners | Indian TV channels | Indian financial analysts | Multinational Companies in India | Tamil Businesspeople | Time Magazine Persons Of The Year | Stock Traders
Explore Moneycontrol
| NEWS |
| Business News |
| Management Interviews (transcripts) |
| Economic News |
| BSE&NSE Notices |
| CNBC-TV18 Transcripts |
| EARNINGS |
| Pre Result Estimates |
| Results |
| Boardroom (transcripts) |
| Result Analysis (transcripts) |
| Brokerage Reports |
|
Connect.in.com
URBANEYE